Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its ...
With trademark applications surging, The Detail looks at what it takes to get a mark registered in New Zealand.
The fund posted returns of 2.85%(Institutional shares) and 2.78%(Investor A shares, without sales charge) for the fourth ...
2-Year U.S. Treasury Note Continuous Contract $103.414-0.137-0.13% 5-Year U.S. Treasury Note Continuous Contract $107.664-0.289-0.27% 10-Year U.S. Treasury Note Continuous Contract $110.609-0.328 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results